sequencing of targeted therapies for cll
Published 2 years ago • 165 plays • Length 4:57Download video MP4
Download video MP3
Similar videos
-
1:29
how targeted therapies are sequenced in cll
-
5:51
sequencing targeted therapies in cll after intolerance versus progression
-
1:34
targeted therapies for cll
-
2:43
treatment sequencing options for recurrent cll
-
2:02
the prognostic impact of tp53 and ighv status in the era of targeted therapies in cll
-
1:29
the importance of treatment sequencing in cll
-
9:00
overview of cll therapies and sequencing of therapies
-
2:34
sequencing of therapies in patients with r/r cll
-
4:31
the impact of high and low burden tp53 mutations on risk and treatment decision in cll
-
33:01
thriving with cll: what you should know about care and treatment
-
7:24
what are the current cll treatment options?
-
4:07
overcoming the challenge of resistance to targeted therapies in cll
-
3:48
managing cll treatment in the future: targeted therapies and early intervention
-
1:24
sequencing of btk inhibitors in cll
-
2:02
important prognostic factors to evaluate in cll patients in the era of small molecules
-
1:09
sequencing of therapies to improve outcomes of cll patients
-
2:05
the latest on targeted therapies in cll
-
1:36
using genomics to predict cll progression
-
1:17
relevance of prognostic factors in the era of targeted therapies in cll
-
0:45
key trials in cll and designing a concept for treatment
-
2:06
the role of ibrutinib in the frontline treatment of young patients with cll
-
1:36
selecting the best treatment option in cll